SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

SU

278.6

+3.8%↑

BAS

52.71

-1.53%↓

REP

19.78

-5.63%↓

AM

327

+0.31%↑

EXE.US

95.75

-1.63%↓

Search

H&R GmbH & Co KGaA

Suletud

4.28 4.14

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

4.05

Max

4.33

Põhinäitajad

By Trading Economics

Sissetulek

970K

-662K

Müük

3.3M

311M

Dividenditootlus

2.01

Kasumimarginaal

-0.213

Soovitused

By TipRanks

Soovitused

Müü

12 kuu keskmine prognoos

-14.89% downside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.01%

3.34%

Järgmine tulemuste avaldamine

15. mai 2026

Turustatistika

By TradingEconomics

Turukapital

260M

Eelmine avamishind

0.14

Eelmine sulgemishind

4.28

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

H&R GmbH & Co KGaA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

17. apr 2026, 20:26 UTC

Omandamised, ülevõtmised, äriostud

UCB to Buy Neurona Therapeutics for Up to $1.15 Billion

17. apr 2026, 18:15 UTC

Uudisväärsed sündmused

Fed's Waller: Prolonged Iran Conflict Could Block Path to Rate Cuts

17. apr 2026, 16:49 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI -2-

17. apr 2026, 16:49 UTC

Uudisväärsed sündmused

Week Ahead for FX, Bonds: U.S. Retail Sales, PMI Data Due as Focus Remains on Middle East

17. apr 2026, 22:58 UTC

Tulu

Grupo Aeroportuario Del Pacifico: Announces Filing of 2025 Annual Report and Form 20-F

17. apr 2026, 21:32 UTC

Market Talk

Cerebras IPO Adds to Big Year For AI Firms Going Public -- Market Talk

17. apr 2026, 21:22 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17. apr 2026, 21:22 UTC

Market Talk

Moody's Downgrades Belgium to A1 -- Market Talk

17. apr 2026, 20:52 UTC

Tulu

Schwab Investors Get Spooked by JPMorgan's AI Strategy. The Big Worry Is Cash Sweeps. -- Barrons.com

17. apr 2026, 20:50 UTC

Market Talk
Tulu
Omandamised, ülevõtmised, äriostud

Tech, Media & Telecom Roundup: Market Talk

17. apr 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17. apr 2026, 20:29 UTC

Tulu

These Stocks Are Today's Movers: Royal Caribbean, Dow Inc., Netflix, Intel, Albemarle, Autoliv, Alcoa, and More -- Barrons.com

17. apr 2026, 20:11 UTC

Omandamised, ülevõtmised, äriostud

UCB to Buy Neurona Therapeutics for Up to $1.15B

17. apr 2026, 19:34 UTC

Market Talk
Tulu
Omandamised, ülevõtmised, äriostud

Global Equities Roundup: Market Talk

17. apr 2026, 19:34 UTC

Market Talk
Tulu
Omandamised, ülevõtmised, äriostud

Analysts See Netflix's Deal Commentary as Notable -- Market Talk

17. apr 2026, 19:31 UTC

Market Talk
Uudisväärsed sündmused

Oil Futures Fall on Reopening of Strait of Hormuz -- Market Talk

17. apr 2026, 19:26 UTC

Market Talk

U.S. Natural Gas Futures Edge Up -- Market Talk

17. apr 2026, 19:21 UTC

Market Talk

Albemarle's Outperformance Belies Longer-Term Risks -- Market Talk

17. apr 2026, 19:15 UTC

Market Talk

Danaher Seen Rebounding in 2H After Tools-Sector Weakness -- Market Talk

17. apr 2026, 19:07 UTC

Market Talk

Danaher Faces Tough Comparative but Long‑Term Story Intact -- Market Talk

17. apr 2026, 18:57 UTC

Uudisväärsed sündmused

U.S. Stocks Surge on Hope Iran War Nearing End. Foreign Leaders Have a More Sober View. -- Barrons.com

17. apr 2026, 18:53 UTC

Omandamised, ülevõtmised, äriostud

UCB Expects 2026 Adjusted Ebitda Growth in High Single-Digit to Mid-Teens Percentage Range at Constant Exchange Rates

17. apr 2026, 18:53 UTC

Omandamised, ülevõtmised, äriostud

UCB 2026 Rev Guidance Unchanged

17. apr 2026, 18:52 UTC

Omandamised, ülevõtmised, äriostud

UCB: Neurona Deal to Include $650M Upfront and Up to $500M in Potential Future Milestones

17. apr 2026, 18:52 UTC

Omandamised, ülevõtmised, äriostud

UCB to Acquire Neurona Therapeutics for Up to $1.15B Including Potential Milestones

17. apr 2026, 18:14 UTC

Market Talk
Uudisväärsed sündmused

Precious Metals Close Higher as Stronger Demand Eyed -- Market Talk

17. apr 2026, 18:00 UTC

Uudisväärsed sündmused

Fed's Waller: Quick Resolution in Middle East Could Allow Cuts Later This Year

17. apr 2026, 18:00 UTC

Uudisväärsed sündmused

Fed's Waller: Job Losses May Not Signal Recession Amid Demographic Changes

17. apr 2026, 17:31 UTC

Market Talk
Uudisväärsed sündmused

U.S. Oil Rig Count Down By 1 at 410 -- Market Talk

17. apr 2026, 17:26 UTC

Market Talk
Tulu

Netflix's Ability to Grow Engagement Seen as Up in the Air -- Market Talk

Võrdlus sarnastega

Hinnamuutus

H&R GmbH & Co KGaA Prognoos

Hinnasiht

By TipRanks

-14.89% langus

12 kuu keskmine prognoos

Keskmine 3.6 EUR  -14.89%

Kõrge 3.6 EUR

Madal 3.6 EUR

Põhineb 1 Wall Streeti analüütiku instrumendi H&R GmbH & Co KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Müü

1 ratings

0

Osta

0

Hoia

1

Müü

Tehniline skoor

By Trading Central

3.94 / 4Toetus ja vastupanu

Lühikene perspektiiv

Bearish Evidence

Keskpikk perspektiiv

Weak Bullish Evidence

Pikk perspektiiv

Bullish Evidence

Finantsandmed

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

Ärikasum

$

Ettevõttest H&R GmbH & Co KGaA

H&R GmbH & Co. KGaA
help-icon Live chat